Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group

about

Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group

Item

http://www.wikidata.org/entity/Q58801965

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2018

@uk

name

Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group

@en

Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group

@nl

type

Item

label

Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group

@en

Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group

@nl

prefLabel

Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group

@en

Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group

@nl

P1476

Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group

@en

P2093

Abhishek Kakroo

http://www.w3.org/2001/XMLSchema#string

Ajay Bapna

http://www.w3.org/2001/XMLSchema#string

Ajay Gogia

http://www.w3.org/2001/XMLSchema#string

Amish Vora

http://www.w3.org/2001/XMLSchema#string

Anand Pathak

http://www.w3.org/2001/XMLSchema#string

Anu Korula

http://www.w3.org/2001/XMLSchema#string

Anupam Chakrapani

http://www.w3.org/2001/XMLSchema#string

Dinesh Doval

http://www.w3.org/2001/XMLSchema#string

Gaurav Prakash

http://www.w3.org/2001/XMLSchema#string

Ghanashyam Biswas

http://www.w3.org/2001/XMLSchema#string

P2860

Mantle cell lymphoma: evolving management strategies

Report of the Committee on Hodgkin's Disease Staging Classification

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Epidemiology of Non-Hodgkin's Lymphoma in India.

An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.

Clinical staging of chronic lymphocytic leukemia.

P2888

s12288-018-0991-4

P304

398-421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12288-018-0991-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30127547

http://www.w3.org/2001/XMLSchema#string

P921

hematology

P932

6081314

http://www.w3.org/2001/XMLSchema#string